Eytan Ruppin, Chief of the Cancer Data Science Laboratory, shared a post on X about recent article by him and colleagues published in Cancer Discovery:
“How does ancestry influence cancer treatment in clinical trials? In collab with Leng Han and Dr. Gordon Mills, we uncovered ancestry differences in trials, actionable genes, and several types of therapies.
Authors: Mei Luo, Jingwen Yang, Eytan Ruppin, Leng Han, Gordon Mills et al.
More posts featuring Eytan Ruppin.